AstraZeneca Pharmaceuticals LP
GPTKB entity
Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:employs |
thousands
|
| gptkbp:focusesOn |
immunology
oncology cardiovascular diseases respiratory diseases |
| gptkbp:foundedYear |
1999
|
| gptkbp:headquartersLocation |
gptkb:Wilmington,_Delaware,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
AstraZeneca Pharmaceuticals LP
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:legalForm |
gptkb:public_company
|
| gptkbp:parentCompany |
gptkb:AstraZeneca_plc
|
| gptkbp:products |
prescription medicines
|
| gptkbp:subsidiary |
gptkb:AstraZeneca_plc
|
| gptkbp:website |
https://www.astrazeneca-us.com/
|
| gptkbp:bfsParent |
gptkb:AstraZeneca
|
| gptkbp:bfsLayer |
5
|